Patent ID: 8734793

Claim:
An immunodiagnostic reagent comprising one or more recombinant antibodies that specifically bind to a diagnostically relevant region of a hepatitis C virus (HCV) protein, wherein said one or more recombinant antibodies comprises a V H region and V L regions selected from the group consisting of: (a) a V H region comprising the amino acid sequence of SEQ ID NO:9 and a V L region comprising the amino acid sequence of SEQ ID NO:10; and (b) a V H region comprising, in order, (i) the complementarity determining region (CDR) of SEQ ID NO:54, (ii) the CDR of SEQ ID NO:55, and (iii) the CDR of SEQ ID NO:56 and a V L region comprising, in order, (i) the CDR of SEQ ID NO:57, (ii) the CDR of SEQ ID NO:58, and (iii) the CDR of SEQ ID NO:59.